Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $46.8 million.

  • Haemonetics' Shares Outstanding fell 677.97% to $46.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.8 million, marking a year-over-year decrease of 677.97%. This contributed to the annual value of $48.2 million for FY2025, which is 506.41% down from last year.
  • As of Q4 2025, Haemonetics' Shares Outstanding stood at $46.8 million, which was down 677.97% from $46.7 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Shares Outstanding registered a high of $51.3 million during Q3 2022, and its lowest value of $46.7 million during Q3 2025.
  • For the 5-year period, Haemonetics' Shares Outstanding averaged around $50.1 million, with its median value being $50.7 million (2023).
  • Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 108.5% in 2021, then crashed by 721.25% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Shares Outstanding stood at $51.1 million in 2021, then dropped by 1.21% to $50.4 million in 2022, then grew by 0.68% to $50.8 million in 2023, then dropped by 1.08% to $50.2 million in 2024, then dropped by 6.78% to $46.8 million in 2025.
  • Its last three reported values are $46.8 million in Q4 2025, $46.7 million for Q3 2025, and $48.2 million during Q2 2025.